Why are Streptomyces species important for antibiotic production?

Streptomyces are filamentous soil bacteria producing approximately 70% of clinically used antibiotics. Key features: large genomes (8-12 Mb) with extensive biosynthetic gene clusters, complex developmental cycle with antibiotic production during differentiation, production of diverse compound classes (polyketides, nonribosomal peptides, aminoglycosides), and natural selection for antibiotics in competitive soil environments. Important products: streptomycin, erythromycin, tetracycline, chloramphenicol, vancomycin, and daptomycin. Industrial challenges: complex regulation of biosynthetic pathways, cryptic gene clusters requiring activation, morphological complexity affecting fermentation, and genetic instability. Genome mining has revealed many unexpressed biosynthetic pathways. Heterologous expression in engineered hosts enables production of natural products from unculturable organisms.